Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue ...
It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening. Financial Insights: Exact Sciences Market Capitalization ...
It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening. Exact Sciences's Economic Impact: An Analysis Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback